A Genentech lobbyist who generated enormous sales for the company allegedly kept millions in consulting payments to himself.

Pfizer wasted little time in appealing the record £85 million fine imposed by a U.K. cost watchdog for a supply scheme that resulted in a 2,600% price increase…

Pfizer CEO Ian Read says he is “enthusiastic” about some of the potential changes President Trump is proposing for healthcare, like tax reform and regulatory…

Biogen says it received a subpoena from the feds in December relating to rebate payments and Biogen's co-pay assistance programs for Tecfidera and other…

The EpiPen saga isn’t over. The FTC is investigating Mylan's efforts to stave off generic versions of its blockbuster device.

Pharma CEOs got marching orders from President Trump on Tuesday morning: Lower "astronomical" prices, give us "better innovation" and make…

Allergan, Merck, Novartis and Eli Lilly so far are the only Big Pharmas to speak on President Trump's executive order blocking citizens of seven Muslim-…

Johnson & Johnson CEO Alex Gorsky said there are aspects of the ACA that can help patients and lower costs for the country and should be maintained.

Regulatory